Cochrane Abstracts
Surfactant therapy guided by tests for lung maturity in preterm infants at risk of respiratory distress syndrome
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Surfactant Therapy Guided By Tests for Lung Maturity in Preterm Infants at Risk of Respiratory Distress Syndrome." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/440570/1/Surfactant_therapy_guided_by_tests_for_lung_maturity_in_preterm_infants_at_risk_of_respiratory_distress_syndrome.
Surfactant therapy guided by tests for lung maturity in preterm infants at risk of respiratory distress syndrome. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440570/1/Surfactant_therapy_guided_by_tests_for_lung_maturity_in_preterm_infants_at_risk_of_respiratory_distress_syndrome. Accessed January 24, 2025.
Surfactant therapy guided by tests for lung maturity in preterm infants at risk of respiratory distress syndrome. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440570/1/Surfactant_therapy_guided_by_tests_for_lung_maturity_in_preterm_infants_at_risk_of_respiratory_distress_syndrome
Surfactant Therapy Guided By Tests for Lung Maturity in Preterm Infants at Risk of Respiratory Distress Syndrome [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 24]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/440570/1/Surfactant_therapy_guided_by_tests_for_lung_maturity_in_preterm_infants_at_risk_of_respiratory_distress_syndrome.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Surfactant therapy guided by tests for lung maturity in preterm infants at risk of respiratory distress syndrome
ID - 440570
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/440570/1/Surfactant_therapy_guided_by_tests_for_lung_maturity_in_preterm_infants_at_risk_of_respiratory_distress_syndrome
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
